Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 1/20 | 0.41 |
| ▸ | F9 | P00740 | 3/20 | 0.36 |
| ▸ | ESR1 | P03372 | 1/20 | 0.34 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.34 |
| ▸ | S1PR5 | Q9H228 | 7/20 | 0.33 |
| ▸ | S1PR4 | O95977 | 6/20 | 0.33 |
| ▸ | TNKS | O95271 | 1/20 | 0.33 |
| ▸ | TNKS2 | Q9H2K2 | 1/20 | 0.33 |
| ▸ | PARP14 | Q460N5 | 1/20 | 0.32 |
| ▸ | LIMK1 | P53667 | 1/20 | 0.32 |
| ▸ | PIM3 | Q86V86 | 2/20 | 0.31 |
| ▸ | PIM1 | P11309 | 1/20 | 0.31 |
| ▸ | PIM2 | Q9P1W9 | 1/20 | 0.31 |
| ▸ | SLC9A1 | P19634 | 1/20 | 0.31 |
| ▸ | CRHR1 | P34998 | 1/20 | 0.31 |
| ▸ | PRKDC | P78527 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22255465 | 0.97 | ALOX5 (0.41) | ALOX5F9ESR1ESR2S1PR5 | |
| SCHEMBL24841744 | 0.96 | ALOX5 (0.39) | ALOX5F9ESR1ESR2S1PR5 | |
| SCHEMBL24842235 | 0.96 | ALOX5 (0.39) | ALOX5F9ESR1ESR2S1PR5 | |
| SCHEMBL23180830 | 0.96 | ALOX5 (0.39) | ALOX5F9ESR1ESR2S1PR5 | |
| SCHEMBL23179577 | 0.96 | ALOX5 (0.39) | ALOX5F9ESR1ESR2S1PR5 | |
| SCHEMBL22255513 | 0.94 | ALOX5 (0.41) | ALOX5F9ESR1ESR2S1PR5 | |
| SCHEMBL21203299 | 0.94 | ALOX5 (0.39) | ALOX5F9ESR1ESR2S1PR5 | |
| SCHEMBL24841829 | 0.93 | ALOX5 (0.42) | ALOX5F9ESR1ESR2S1PR5 | |
| SCHEMBL24841482 | 0.93 | ALOX5 (0.42) | ALOX5F9ESR1ESR2S1PR5 | |
| SCHEMBL24945336 | 0.93 | ALOX5 (0.41) | ALOX5F9ESR1ESR2S1PR5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200235297-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND MONOAMINE COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2020-07-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200235297-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND MONOAMINE COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE | SLC18A2, SLC18A1, MAOA | ALOX5 1851/4885F9 2570/4885ESR1 537/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.